6.2.6.11
Upon request, the Laboratory shall report in a format specified by WADA, a summary of the results of all tests performed. No information that could link an Athlete with an individual result will be included. The report will include a summary of any Samples rejected for testing and the reason for the rejection.
6.2.6.12
The documentation package should be provided by the Laboratory only to the relevant result management authority upon request and should be provided within 10 working days of the request. Laboratory Documentation Packages shall be in compliance with the WADA Technical Document on Laboratory Documentation Packages.
6.2.6.13
Athlete confidentiality shall be a key concern for all Laboratories engaged in Doping Control cases.
6.2.6.13.1.1 Testing Authority requests for information shall be made in writing to the Laboratories. 6.2.6.13.1.2 Adverse Analytical telephone.
Findings
shall
not
be
provided
by
6.2.6.13.1.3 Information sent by a facsimile is acceptable if the security of the receiving facsimile machine has been verified and procedures are in place to ensure that the facsimile has been transmitted to the correct facsimile number. 6.2.6.13.1.4 Unencrypted email is not authorized for any reporting or discussion of Adverse Analytical Findings if the Athlete can be identified or if any information regarding the identity of the Athlete is included. 6.2.6.13.1.5 The Laboratory shall also provide any information by WADA in conjunction with the Monitoring Program, as set forth in Article 4.5 of the Code.
6.3 Quality Management Processes The Laboratory management requirements listed under ISL Section 5.3 shall apply.
6.4 Support processes Except as modified below, the Laboratory support requirements listed under ISL Section 5.4 shall apply. Accordingly, numbering below is not consecutive, but instead, only those sections where changes from Section 5.4 have been made are included.
International Standard for Laboratories Version 7.0, January 2012
73